UTRS (Minerva Surgical) EBITDA Margin %: -38.11% (As of Sep. 2023)


What is Minerva Surgical EBITDA Margin %?

Minerva Surgical UTRS -99.00% EBITDA Margin % is -38.11% as of Sep. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Minerva Surgical's EBITDA for the three months ended in Sep. 2023 was $-4.56 Mil. Minerva Surgical's Revenue for the three months ended in Sep. 2023 was $11.97 Mil. Therefore, Minerva Surgical's EBITDA margin for the quarter that ended in Sep. 2023 was -38.11%.

Minerva Surgical  (OTCPK:UTRS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Minerva Surgical EBITDA Margin % Related Terms

Minerva Surgical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical EBITDA Margin % Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
-126.06 2.17 1.71 -39.91

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.77 -17.78 -61.92 -41.30 -38.11

UTRS vs PAVM, ELUT, COCH: EBITDA Margin % Comparison

For the Medical Devices subindustry, Minerva Surgical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minerva Surgical EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Minerva Surgical's EBITDA Margin % falls into.


Minerva Surgical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Minerva Surgical's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-20.073/50.294
=-39.91 %

Minerva Surgical's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-4.56/11.965
=-38.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -38.11% mean?
Minerva Surgical (UTRS) has a EBITDA Margin % of -38.11% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Minerva Surgical and its competitors.
Is Minerva Surgical's EBITDA Margin % too high?
Minerva Surgical's current EBITDA Margin % is -38.11%.
How does Minerva Surgical's EBITDA Margin % compare to PAVM and ELUT?
Minerva Surgical's EBITDA Margin % of -38.11% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Minerva Surgical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minerva Surgical's current EBITDA Margin % is -38.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current EBITDA Margin % of -38.11%. The current EBITDA Margin % is -38.11%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current EBITDA Margin % is -38.11% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.